Skip to main content
. 2017 Apr 20;12(4):e0174767. doi: 10.1371/journal.pone.0174767

Fig 5. Intention-to-treat analysis of the proportion of virological success (400 copies/mL) at 24 months of ART by study design.

Fig 5